Hims & Hers Health (HIMS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

HWM surges on aerospace demand, rising earnings, and upgraded guidance, while SQM stumbles on weak results and estimate cuts.

New York City is experiencing a consumer tech renaissance, attracting startups and investors. The Bay Area still leads in ...

The Hawkeye star died momentarily when he was crushed under a snowplough - and he says he did not want to return ...

Salem Investment Counselors Inc. bought a new stake in shares of Hims & Hers Health, Inc. (NYSE:HIMS - Free Report) during the 1st quarter, according to its most recent disclosure with the Securities ...

QIAGEN N.V. QGEN is well-poised to grow in the upcoming quarters, courtesy of substantial investment in research and development (R&D) for the menu expansion of its key platforms. Expanding through ...

The United States market has experienced a positive trajectory, with a 1.6% increase over the last week and a 12% rise over the past year, alongside an anticipated annual earnings growth of 14%. In ...

Eli Lilly found itself in a pharmaceutical pickle after its CFO claimed telehealth partners don’t compound key weight-loss ...